The Medicines Company Announces Clive Meanwell, MD, PhD, Chief Executive Officer, Is the Recipient of BioNJ Award

On Feb 5, 2016

Parsippany-based The Medicines Company today announced that its founder and Chief Executive Officer, Clive Meanwell, MD, PhD, has been awarded the 2016 Dr. Sol J. Barer Award for Vision, Innovation, and Leadership. Named for Sol J. Barer, PhD, founder and former Chairman and Chief Executive Officer of Celgene Corporation of Summit, the award recognizes outstanding research and business leaders who have made significant contributions to the growth and prosperity of the biosciences industry in New Jersey and throughout the world.

The award was presented last evening during ceremonies celebrating BioNJ’s 23rd Annual Dinner Meeting and Networking Event held at the Hilton East Brunswick.

“Dr. Sol Barer is an icon of the bioscience industry, and his dedication and commitment to innovation is nothing short of inspirational. I humbly accept this award on behalf of all of my colleagues at The Medicines Company who achieved so much during 2015 – and we thank the BioNJ Board of Trustees for this honor,” said Clive Meanwell, MD, PhD, Chief Executive Officer, The Medicines Company.

“Clive is everything a leader should be: a visionary who’s not afraid to challenge the status quo, an innovator who’s respected by patients and caregivers for his compassion and commitment to better understand their challenges, and a leader who knows how to get the job done and how to inspire a team to travel that road with him,” said Debbie Hart, President and Chief Executive Officer, BioNJ. “Since its inception in 1996, Clive has carefully guided The Medicines Company to the innovative institution it is today – known for developing products that industry experts have dubbed ‘game-changers’ in treating cardiovascular disease, infectious disease and sedation. At the same time, Clive has long been committed to understanding how customers value medicines, and ensuring the company delivers both medical and economic improvements that create value and build a sustainable business. Clive is so deserving of this award.”

At the same event, The Medicines Company was one of 16 companies who received a BioNJ Innovator Award for a new drug approval in 2015. The company had four drug approvals in the U.S. in 2015.

Related Articles: